CDTX (Cidara Therapeutics) Volume dana dhuwit perusahaan

Lambang korporat lan logo Cidara Corp (CDTX)

Cidara Therapeutics (CDTX) is implementing the Cloudbreak platform to develop extended-release immunotherapeutic agents. Proprietary hospital drugs ensure stable demand and procurement resilience. Independence from macroeconomic factors renders the asset a defensive asset during a recession. The free cash flow metric demonstrates business liquidity, with the value recorded at 0.40, confirming the company's current solvency.

Cidara Therapeutics Corp - Sisa dhuwit perusahaan CDTX (periode 04.07.2022 - 17.01.2026)

Rincian metrik keuangan lan pasar cidara.com (CDTX)

- nilai saham lan prakiraan konsensus rega:
Analisis kabeh metrik perusahaan:CDTX Cidara Therapeutics Inc
Produk merek Cidara Therapeutics

Selecting assets with a high margin of safety requires an analysis of liquidity as an absolute indicator of available funds to cover operating expenses. This metric captures the current safety cushion, which is critical for Cidara Therapeutics (CDTX) when financing the development of immunotherapeutic drugs and allocating clinical trial risks, reflecting the trend of physical cash holdings.